CN116323638A - 订书钉化肽及其方法 - Google Patents

订书钉化肽及其方法 Download PDF

Info

Publication number
CN116323638A
CN116323638A CN202180064601.7A CN202180064601A CN116323638A CN 116323638 A CN116323638 A CN 116323638A CN 202180064601 A CN202180064601 A CN 202180064601A CN 116323638 A CN116323638 A CN 116323638A
Authority
CN
China
Prior art keywords
agent
independently
group
optionally substituted
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202180064601.7A
Other languages
English (en)
Chinese (zh)
Inventor
布赖恩·哈尔伯特·怀特
司亚光
马丁·罗伯特·特朗布莱
黛博拉·盖尔·康拉迪
章越梅
伊凡·塔克·朱伊特
洛伦佐·若苏埃·阿尔法罗-洛佩斯
莎拉·伊莎贝尔·卡普奇
李志�
约翰·汉尼·麦吉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vogel Pharmaceutical Co ltd
Original Assignee
Vogel Pharmaceutical Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vogel Pharmaceutical Co ltd filed Critical Vogel Pharmaceutical Co ltd
Publication of CN116323638A publication Critical patent/CN116323638A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CN202180064601.7A 2020-07-22 2021-07-22 订书钉化肽及其方法 Pending CN116323638A (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202063055308P 2020-07-22 2020-07-22
US63/055,308 2020-07-22
US202163208494P 2021-06-08 2021-06-08
US63/208,494 2021-06-08
PCT/US2021/042856 WO2022020652A2 (en) 2020-07-22 2021-07-22 Stapled peptides and methods thereof

Publications (1)

Publication Number Publication Date
CN116323638A true CN116323638A (zh) 2023-06-23

Family

ID=79728982

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202180064601.7A Pending CN116323638A (zh) 2020-07-22 2021-07-22 订书钉化肽及其方法

Country Status (10)

Country Link
US (1) US20240116985A1 (https=)
EP (1) EP4185599A4 (https=)
JP (1) JP2023535026A (https=)
KR (1) KR20230057350A (https=)
CN (1) CN116323638A (https=)
AU (1) AU2021314310A1 (https=)
CA (1) CA3186681A1 (https=)
IL (1) IL299907A (https=)
MX (1) MX2023000947A (https=)
WO (1) WO2022020652A2 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2018329956A1 (en) 2017-09-07 2020-08-20 Fog Pharmaceuticals, Inc. Agents modulating beta-catenin functions and methods thereof
MX2021001943A (es) 2018-08-20 2021-07-15 Fog Pharmaceuticals Inc Colecciones de péptidos, agentes peptídicos y métodos de uso de los mismos.
KR20240031957A (ko) * 2021-06-08 2024-03-08 포그 파마슈티컬스 인코포레이티드 스테이플화된 펩티드 및 이의 방법
CN115260060A (zh) * 2022-09-07 2022-11-01 康化（上海）新药研发有限公司 (2s)-2-n-芴甲氧羰基氨基-5,5-二甲基正亮氨酸的合成方法
WO2024054892A1 (en) * 2022-09-09 2024-03-14 Shape Therapeutics Inc. Therapeutic peptides
WO2024130217A1 (en) * 2022-12-15 2024-06-20 Fog Pharmaceuticals, Inc. Stapled peptides and methods thereof
CN120529912A (zh) * 2022-12-15 2025-08-22 帕拉比利斯药物公司 订书钉化肽及其方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5671196A (en) * 1996-03-28 1997-10-17 Immulogic Pharmaceutical Corporation Myelin oligodendrocyte glycoprotein peptides and uses thereof
US20040181830A1 (en) * 2001-05-07 2004-09-16 Kovalic David K. Nucleic acid molecules and other molecules associated with plants and uses thereof for plant improvement
US20050187147A1 (en) * 2003-09-22 2005-08-25 Newman Michael J. Compositions and methods for increasing drug efficiency
EP2254592B1 (en) * 2008-02-28 2019-06-05 Dako Denmark A/S Mhc multimers in borrelia diagnostics and disease
WO2010009987A2 (en) * 2008-07-21 2010-01-28 Probiodrug Ag Diagnostic antibody assay
EP2337795A2 (en) * 2008-10-01 2011-06-29 Dako Denmark A/S Mhc multimers in cancer vaccines and immune monitoring
WO2012040459A2 (en) * 2010-09-22 2012-03-29 President And Fellows Of Harvard College Beta-catenin targeting peptides and uses thereof
WO2014026033A1 (en) * 2012-08-08 2014-02-13 University Of Florida Research Foundation, Inc. Cross-reactive t cell epitopes of hiv, siv, and fiv for vaccines in humans and cats
GB2563875B (en) * 2017-06-28 2020-08-19 Sutura Therapeutics Ltd Improvements in drug delivery
AU2018329956A1 (en) * 2017-09-07 2020-08-20 Fog Pharmaceuticals, Inc. Agents modulating beta-catenin functions and methods thereof
WO2019178313A1 (en) * 2018-03-14 2019-09-19 Dana-Farber Cancer Institute, Inc. Stabilized peptides for biomarker detection

Also Published As

Publication number Publication date
JP2023535026A (ja) 2023-08-15
MX2023000947A (es) 2023-02-22
WO2022020652A3 (en) 2022-03-03
AU2021314310A1 (en) 2023-03-16
KR20230057350A (ko) 2023-04-28
EP4185599A4 (en) 2024-08-28
CA3186681A1 (en) 2022-01-27
US20240116985A1 (en) 2024-04-11
IL299907A (en) 2023-03-01
EP4185599A2 (en) 2023-05-31
WO2022020652A2 (en) 2022-01-27

Similar Documents

Publication Publication Date Title
CN116323638A (zh) 订书钉化肽及其方法
JP2022043073A (ja) 二価ブロモドメインインヒビターおよびそれらの使用
JP2021514958A (ja) 選択的なタンパク質分解を誘導するための低分子およびその使用法
AU2019362788A1 (en) Transcriptional enhanced associate domain (TEAD) transcription factor inhibitors and uses thereof
KR20240031957A (ko) 스테이플화된 펩티드 및 이의 방법
US20230128688A1 (en) Directed conjugation technologies
WO2015117083A1 (en) Diazepane derivatives and uses thereof
WO2015117087A1 (en) Uses of diazepane derivatives
JP2019510810A (ja) インドールアミン−２，３−ジオキシゲナーゼ（ｉｄｏ）阻害剤
CN115697415A (zh) 用于预防或治疗感染的技术
CN116113621A (zh) 氨基酸
JP2024517183A (ja) 転写増強アソシエートドメイン（ｔｅａｄ）転写因子阻害剤及びその使用
JP2025541247A (ja) ステープルペプチドおよびその方法
JP2025541246A (ja) ステープルペプチドおよびその方法
WO2024220676A1 (en) Mrna degraders and methods of use thereof
WO2022170155A2 (en) Technologies for preventing or treating infections
HK40129655A (zh) 订书钉化肽及其方法
HK40108355A (zh) 订书钉化肽及其方法
HK40128981A (zh) 订书钉化肽及其方法
US20240391956A1 (en) Stapled peptides and methods thereof
CN117794560A (zh) 订书钉化肽及其方法
KR20260035134A (ko) 스테이플화 펩티드 및 이의 방법
AU2023418787A1 (en) Naphthylamide compound, and preparation method therefor and use thereof
WO2025265097A1 (en) Stapled peptides and methods thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
CB02 Change of applicant information

Country or region after: U.S.A.

Address after: Massachusetts, USA

Applicant after: Paris Pharmaceutical Co.

Address before: Massachusetts, USA

Applicant before: Vogel Pharmaceutical Co.,Ltd.

Country or region before: U.S.A.

CB02 Change of applicant information